Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 240

1.

MiR-487a resensitizes mitoxantrone (MX)-resistant breast cancer cells (MCF-7/MX) to MX by targeting breast cancer resistance protein (BCRP/ABCG2).

Ma MT, He M, Wang Y, Jiao XY, Zhao L, Bai XF, Yu ZJ, Wu HZ, Sun ML, Song ZG, Wei MJ.

Cancer Lett. 2013 Oct 1;339(1):107-15. doi: 10.1016/j.canlet.2013.07.016. Epub 2013 Jul 20.

PMID:
23879965
[PubMed - indexed for MEDLINE]
2.

MiR-181a enhances drug sensitivity in mitoxantone-resistant breast cancer cells by targeting breast cancer resistance protein (BCRP/ABCG2).

Jiao X, Zhao L, Ma M, Bai X, He M, Yan Y, Wang Y, Chen Q, Zhao X, Zhou M, Cui Z, Zheng Z, Wang E, Wei M.

Breast Cancer Res Treat. 2013 Jun;139(3):717-30. doi: 10.1007/s10549-013-2607-x. Epub 2013 Jun 19.

PMID:
23780685
[PubMed - indexed for MEDLINE]
3.

Co-expression of cytokeratin 8 and breast cancer resistant protein indicates a multifactorial drug-resistant phenotype in human breast cancer cell line.

Liu F, Fan D, Qi J, Zhu H, Zhou Y, Yang C, Zhu Z, Xiong D.

Life Sci. 2008 Sep 26;83(13-14):496-501. doi: 10.1016/j.lfs.2008.07.017. Epub 2008 Aug 3.

PMID:
18725232
[PubMed - indexed for MEDLINE]
4.

MicroRNA-328 negatively regulates the expression of breast cancer resistance protein (BCRP/ABCG2) in human cancer cells.

Pan YZ, Morris ME, Yu AM.

Mol Pharmacol. 2009 Jun;75(6):1374-9. doi: 10.1124/mol.108.054163. Epub 2009 Mar 6.

PMID:
19270061
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

[Regulation mechanism of breast cancer resistance protein by toremifene to reverse BCRP-mediated multidrug resistance in breast cancer cells].

Zhang YH, Li G, Yu J, Xu MS, Liu ZX.

Zhonghua Zhong Liu Za Zhi. 2011 Sep;33(9):654-60. Chinese.

PMID:
22340044
[PubMed - indexed for MEDLINE]
6.

Developing multidrug-resistant cells and exploring correlation between BCRP/ABCG2 over-expression and DNA methyltransferase.

Ji N, Yuan J, Liu J, Tian S.

Acta Biochim Biophys Sin (Shanghai). 2010 Dec;42(12):854-62. doi: 10.1093/abbs/gmq097.

PMID:
21106767
[PubMed - indexed for MEDLINE]
7.

Atypical multidrug resistance: breast cancer resistance protein messenger RNA expression in mitoxantrone-selected cell lines.

Ross DD, Yang W, Abruzzo LV, Dalton WS, Schneider E, Lage H, Dietel M, Greenberger L, Cole SP, Doyle LA.

J Natl Cancer Inst. 1999 Mar 3;91(5):429-33.

PMID:
10070941
[PubMed - indexed for MEDLINE]
Free Article
8.

Transcriptional modulation of BCRP gene to reverse multidrug resistance by toremifene in breast adenocarcinoma cells.

Zhang Y, Wang H, Wei L, Li G, Yu J, Gao Y, Gao P, Zhang X, Wei F, Yin D, Zhou G.

Breast Cancer Res Treat. 2010 Oct;123(3):679-89. doi: 10.1007/s10549-009-0660-2. Epub 2009 Dec 6.

PMID:
19967559
[PubMed - indexed for MEDLINE]
9.

Survivin up-regulates the expression of breast cancer resistance protein (BCRP) through attenuating the suppression of p53 on NF-κB expression in MCF-7/5-FU cells.

Wang QP, Wang Y, Wang XD, Mo XM, Gu J, Lu ZY, Pan ZL, Zhu YX.

Int J Biochem Cell Biol. 2013 Sep;45(9):2036-44. doi: 10.1016/j.biocel.2013.06.026. Epub 2013 Jul 6.

PMID:
23838170
[PubMed - indexed for MEDLINE]
10.

MiR-222 and miR-29a contribute to the drug-resistance of breast cancer cells.

Zhong S, Li W, Chen Z, Xu J, Zhao J.

Gene. 2013 Nov 15;531(1):8-14. doi: 10.1016/j.gene.2013.08.062. Epub 2013 Aug 29.

PMID:
23994196
[PubMed - indexed for MEDLINE]
11.

Resistance to mitoxantrone in multidrug-resistant MCF7 breast cancer cells: evaluation of mitoxantrone transport and the role of multidrug resistance protein family proteins.

Diah SK, Smitherman PK, Aldridge J, Volk EL, Schneider E, Townsend AJ, Morrow CS.

Cancer Res. 2001 Jul 15;61(14):5461-7.

PMID:
11454692
[PubMed - indexed for MEDLINE]
Free Article
12.

Interleukin-1 beta and tumor necrosis factor-alpha increase ABCG2 expression in MCF-7 breast carcinoma cell line and its mitoxantrone-resistant derivative, MCF-7/MX.

Mosaffa F, Lage H, Afshari JT, Behravan J.

Inflamm Res. 2009 Oct;58(10):669-76. doi: 10.1007/s00011-009-0034-6. Epub 2009 Mar 31.

PMID:
19333723
[PubMed - indexed for MEDLINE]
13.

Estrogen-mediated post transcriptional down-regulation of breast cancer resistance protein/ABCG2.

Imai Y, Ishikawa E, Asada S, Sugimoto Y.

Cancer Res. 2005 Jan 15;65(2):596-604.

PMID:
15695404
[PubMed - indexed for MEDLINE]
Free Article
14.

Breast cancer resistance protein BCRP/ABCG2 regulatory microRNAs (hsa-miR-328, -519c and -520h) and their differential expression in stem-like ABCG2+ cancer cells.

Li X, Pan YZ, Seigel GM, Hu ZH, Huang M, Yu AM.

Biochem Pharmacol. 2011 Mar 15;81(6):783-92. doi: 10.1016/j.bcp.2010.12.018. Epub 2011 Jan 8.

PMID:
21219875
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Reversal of breast cancer resistance protein (BCRP/ABCG2)-mediated drug resistance by novobiocin, a coumermycin antibiotic.

Shiozawa K, Oka M, Soda H, Yoshikawa M, Ikegami Y, Tsurutani J, Nakatomi K, Nakamura Y, Doi S, Kitazaki T, Mizuta Y, Murase K, Yoshida H, Ross DD, Kohno S.

Int J Cancer. 2004 Jan 1;108(1):146-51.

PMID:
14618629
[PubMed - indexed for MEDLINE]
16.

Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2).

Doyle L, Ross DD.

Oncogene. 2003 Oct 20;22(47):7340-58. Review.

PMID:
14576842
[PubMed - indexed for MEDLINE]
17.

Evaluation of indomethacin and dexamethasone effects on BCRP-mediated drug resistance in MCF-7 parental and resistant cell lines.

Elahian F, Kalalinia F, Behravan J.

Drug Chem Toxicol. 2010 Apr;33(2):113-9. doi: 10.3109/01480540903390000.

PMID:
20307139
[PubMed - indexed for MEDLINE]
18.
19.

Multidrug resistance in breast cancer cells during epithelial-mesenchymal transition is modulated by breast cancer resistant protein.

Chen WJ, Wang H, Tang Y, Liu CL, Li HL, Li WT.

Chin J Cancer. 2010 Feb;29(2):151-7.

PMID:
20109342
[PubMed - indexed for MEDLINE]
Free Article
20.

Gefitinib ("Iressa", ZD1839), an epidermal growth factor receptor tyrosine kinase inhibitor, reverses breast cancer resistance protein/ABCG2-mediated drug resistance.

Nakamura Y, Oka M, Soda H, Shiozawa K, Yoshikawa M, Itoh A, Ikegami Y, Tsurutani J, Nakatomi K, Kitazaki T, Doi S, Yoshida H, Kohno S.

Cancer Res. 2005 Feb 15;65(4):1541-6.

PMID:
15735043
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk